The Novel Cyclophilin Inhibitor CPI-431-32 Concurrently Blocks HCV and HIV-1 Infections via a Similar Mechanism of Action
Philippe Gallay(Scripps Research Institute), Robert T. Foster(Edison Pharmaceuticals (United States)), Udayan Chatterji(Scripps Research Institute), Cosme Ordonez, Daren Ure(NAEJA-RGM Pharmaceuticals (Canada)), Daniel J. Trepanier(Scripps Research Institute), Michael Bobardt(Scripps Research Institute)
Cited by 37
Related Papers
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
|Science|1996|4.9k
HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway
|Proceedings of the National Academy of Sciences|1997|483
HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase
|Cell|1995|355
Active Site Residues of Cyclophilin A Are Crucial for Its Signaling Activity via CD147
|Journal of Biological Chemistry|2002|338